The FDA has long campaigned for its abolition because of its effect on patients in deprived areas.
Dr Michael Taylor, FDA chairman, said: ‘Though the FDA applauds these changes, there remains much work to be done to ensure that the money follows the patient in areas of greatest deprivation.’
Other agreed changes include the phasing out of the MPIG and the reallocation of 72 quality framework points.
Mike Ramsden, chief executive of the National Association of Primary Care (NAPC), said: ‘There will inevitably be some uncertainty amongst the 40 per cent of practices who hold PMS contracts as to how some of these changes will apply to them at local level.
‘PMS contracts are a matter for local negotiation between those PMS practices and PCTs. However, the NAPC will be working with the DoH to provide support to PMS practices and PCTs to ensure the best possible understanding of how these changes to the GMS contract might be applied to PMS contracts, with a view to supporting the delivery of sustained, high quality, patient-responsive health services, tailored to meet local needs.’
neil.durham@haymarket.com
Comment below and tell us what you think
GPs back removal of 'iniquitous' square root formula
The Family Doctor Association (FDA) is delighted to learn that the 'iniquitous' square root formula is to be removed from the GMS contract.
